(Q81069451)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18407765%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

review article

1 reference

title

Antibody-cytokine fusion proteins: applications in cancer therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18407765%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18407765%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Tracy R Daniels-Wells

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18407765%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

author name string

Elizabeth Ortiz-Sánchez

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18407765%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Manuel L Penichet

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18407765%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

publication date

1 May 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18407765%20AND%20SRC:MED&resulttype=core&format=json

Expert Opinion on Biological Therapy

5 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18407765%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18407765%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18407765%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

page(s)

609-632

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18407765%20AND%20SRC:MED&resulttype=core&format=json

Studies of aglycosylated chimeric mouse-human IgG. Role of carbohydrate in the structure and effector functions mediated by the human IgG constant region

5 January 2020

cites work

1 reference

12 December 2020

Antibody-cytokine fusion proteins: harnessing the combined power of cytokines and antibodies for cancer therapy

1 reference

12 December 2020

Cytokines fused to antibodies and their combinations as therapeutic agents against different peritoneal HER2/neu expressing tumors.

1 reference

12 December 2020

An anti-CD20-IL-2 immunocytokine is highly efficacious in a SCID mouse model of established human B lymphoma.

1 reference

12 December 2020

Durability of complete responses in patients with metastatic cancer treated with high-dose interleukin-2: identification of the antigens mediating response

1 reference

12 December 2020

The level of MHC class I expression on murine adenocarcinoma can change the antitumor effector mechanism of immunocytokine therapy.

1 reference

12 December 2020

Effects of single-dose interleukin-12 exposure on interleukin-12-associated toxicity and interferon-gamma production

1 reference

12 December 2020

Antibody engineering for therapeutics

1 reference

12 December 2020

Heterogeneity of mucin gene expression in normal and neoplastic tissues.

1 reference

12 December 2020

Enhancement of the antitumor properties of interleukin-2 by its targeted delivery to the tumor blood vessel extracellular matrix

1 reference

12 December 2020

Recombinant immunocytokines targeting the mouse transferrin receptor: construction and biological activities

1 reference

12 December 2020

Adjuvant subcutaneous interleukin-2 in patients with resected renal cell carcinoma: a pilot study

1 reference

12 December 2020

The history and rationale for monoclonal antibodies in the treatment of hematologic malignancy

1 reference

12 December 2020

Synergistic therapeutic effects of a tumor targeting antibody fragment, fused to interleukin 12 and to tumor necrosis factor alpha

1 reference

12 December 2020

Simultaneous targeting of IL2 and IL12 to Hodgkin's lymphoma cells enhances activation of resting NK cells and tumor cell lysis

1 reference

12 December 2020

Source of oncofetal ED-B-containing fibronectin: implications of production by both tumor and endothelial cells.

1 reference

12 December 2020

The impact of concurrent granulocyte macrophage-colony stimulating factor on radiation-induced mucositis in head and neck cancer patients: a double-blind placebo-controlled prospective phase III study by Radiation Therapy Oncology Group 9901.

1 reference

12 December 2020

Antibody-cytokine fusion proteins for the therapy of cancer

1 reference

12 December 2020

Interleukin-2: use in solid tumors

1 reference

12 December 2020

Regulation of HLA-DR gene by IFN-gamma. Transcriptional and post-transcriptional control

1 reference

12 December 2020

T cell-mediated eradication of murine metastatic melanoma induced by targeted interleukin 2 therapy

1 reference

12 December 2020

Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells.

1 reference

12 December 2020

Circulating HER-2/erbB-2/c-neu (HER-2) extracellular domain as a prognostic factor in patients with metastatic breast cancer: Cancer and Leukemia Group B Study 8662.

1 reference

12 December 2020

Diagnostic Significance of CD20 and FMC7 Expression in B-Cell Disorders

1 reference

12 December 2020

Clinical pharmacology and therapeutic potential of monoclonal antibody treatment in rheumatoid arthritis

1 reference

12 December 2020

Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli

1 reference

12 December 2020

The extracellular domain of p185/neu is released from the surface of human breast carcinoma cells, SK-BR-3

1 reference

12 December 2020

In vivo properties of an IgG3-IL-2 fusion protein. A general strategy for immune potentiation.

1 reference

12 December 2020

Autologous tumor-specific cytotoxic T lymphocytes in the infiltrate of human metastatic melanomas. Activation by interleukin 2 and autologous tumor cells, and involvement of the T cell receptor

1 reference

12 December 2020

Use of rituximab, the new FDA-approved antibody.

1 reference

12 December 2020

Provision of granulocyte-macrophage colony-stimulating factor converts an autoimmune response to a self-antigen into an antitumor response

1 reference

12 December 2020

IFN-gamma induces apoptosis in ovarian cancer cells in vivo and in vitro

1 reference

12 December 2020

Is episialin/MUC1 involved in breast cancer progression?

1 reference

12 December 2020

Expression of human B cell-associated antigens on leukemias and lymphomas: a model of human B cell differentiation

1 reference

12 December 2020

Tumor-specific glycosylation of the carcinoma-associated epithelial cell adhesion molecule EpCAM in head and neck carcinomas

1 reference

12 December 2020

An anti-MUC1-antibody-interleukin-2 fusion protein that activates resting NK cells to lysis of MUC1-positive tumour cells

1 reference

12 December 2020

The role of cytokines in cancer-related fatigue

1 reference

12 December 2020

Immune-mediated side-effects of cytokines in humans

1 reference

12 December 2020

Human/mouse chimeric monoclonal antibodies with human IgG1, IgG2, IgG3 and IgG4 constant domains: electron microscopic and hydrodynamic characterization

1 reference

12 December 2020

An IgG3-IL2 fusion protein activates complement, binds Fc gamma RI, generates LAK activity and shows enhanced binding to the high affinity IL-2R.

1 reference

12 December 2020

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

1 reference

12 December 2020

The mechanism of unresponsiveness to circulating tumor antigen MUC1 is a block in intracellular sorting and processing by dendritic cells

1 reference

12 December 2020

Treatment of B-cell lymphoma with chimeric IgG and single-chain Fv antibody-interleukin-2 fusion proteins

1 reference

12 December 2020

Interleukin-2 toxicity

1 reference

12 December 2020

Cancer immunotherapy with interleukin 12 and granulocyte-macrophage colony-stimulating factor-encapsulated microspheres: coinduction of innate and adaptive antitumor immunity and cure of disseminated disease

1 reference

12 December 2020

Interleukin-12 in anti-tumor immunity and immunotherapy.

1 reference

12 December 2020

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

12 December 2020

Antidisialoganglioside/granulocyte macrophage-colony-stimulating factor fusion protein facilitates neutrophil antibody-dependent cellular cytotoxicity and depends on FcgammaRII (CD32) and Mac-1 (CD11b/CD18) for enhanced effector cell adhesion and az

1 reference

12 December 2020

Efficient growth inhibition of ErbB2-overexpressing tumor cells by anti-ErbB2 ScFv-Fc-IL-2 fusion protein in vitro and in vivo

1 reference

12 December 2020

A recombinant IgG3-(IL-2) fusion protein for the treatment of human HER2/neu expressing tumors

1 reference

12 December 2020

HER2 as a prognostic and predictive marker for breast cancer

1 reference

12 December 2020

Interleukin-2 enhancement of monoclonal antibody-mediated cellular cytotoxicity against human melanoma

1 reference

12 December 2020

Multiple primary cancer: an experience at the Cancer Institute Hospital with special reference to colorectal cancer

1 reference

12 December 2020

Adjuvant-independent enhanced immune responses to recombinant herpes simplex virus type 1 glycoprotein D by fusion with biologically active interleukin-2.

1 reference

12 December 2020

Effect of cloned interferon-gamma on expression of H-2 and Ia antigens on cell lines of hemopoietic, lymphoid, epithelial, fibroblastic and neuronal origin

1 reference

12 December 2020

Anti-HER2/neu IgG3-(IL-2) and anti-HER2/neu IgG3-(GM-CSF) promote HER2/neu processing and presentation by dendritic cells: implications in immunotherapy and vaccination strategies

1 reference

12 December 2020

Natural killer cell-mediated eradication of neuroblastoma metastases to bone marrow by targeted interleukin-2 therapy

1 reference

12 December 2020

IL-12 is a heparin-binding cytokine

1 reference

12 December 2020

Cytokines and T cells in host defense

1 reference

12 December 2020

An engineered antibody-interleukin-12 fusion protein with enhanced tumor vascular targeting properties

1 reference

12 December 2020

Classical Hodgkin's disease. Clinical impact of the immunophenotype

1 reference

12 December 2020

An antibody-interleukin 2 fusion protein overcomes tumor heterogeneity by induction of a cellular immune response

1 reference

12 December 2020

Granulocyte-macrophage colony-stimulating factor: pleiotropic cytokine with potential clinical usefulness

1 reference

12 December 2020

Expression of Ep-CAM in normal, regenerating, metaplastic, and neoplastic liver.

1 reference

12 December 2020

Replacing the complementarity-determining regions in a human antibody with those from a mouse

1 reference

12 December 2020

Protein vaccination with the HER2/neu extracellular domain plus anti-HER2/neu antibody-cytokine fusion proteins induces a protective anti-HER2/neu immune response in mice

1 reference

12 December 2020

Myeloma expression systems

1 reference

12 December 2020

Tumor-directed lymphocyte-activating cytokines: refolding-based preparation of recombinant human interleukin-12 and an antibody variable domain-fused protein by additive-introduced stepwise dialysis.

1 reference

12 December 2020

Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains

1 reference

12 December 2020

Antibodies and their fragments as anti-cancer agents

1 reference

12 December 2020

ED-B fibronectin as a target for antibody-based cancer treatments

1 reference

12 December 2020

A phase I clinical trial of the hu14.18-IL2 (EMD 273063) as a treatment for children with refractory or recurrent neuroblastoma and melanoma: a study of the Children's Oncology Group

1 reference

12 December 2020

Mechanism of antitumor activity of a single-chain interleukin-12 IgG3 antibody fusion protein (mscIL-12.her2.IgG3).

1 reference

12 December 2020

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity

1 reference

12 December 2020

Fatal spleen rupture during induction chemotherapy with rh GM-CSF priming for acute monocytic leukemia. Clinical case report and in vitro studies.

1 reference

12 December 2020

Anti-CD30-scFv-Fc-IL-2 antibody-cytokine fusion protein that induces resting NK cells to highly efficient cytolysis of Hodgkin's lymphoma derived tumour cells

1 reference

12 December 2020

High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: analysis of 270 patients treated between 1985 and 1993

1 reference

12 December 2020

Capacity of human large granular lymphocytes (LGL) to produce multiple lymphokines: interleukin 2, interferon, and colony stimulating factor

1 reference

12 December 2020

Propagation and control of T cell responses by heparan sulfate-bound IL-2

1 reference

12 December 2020

Development of an immunocytokine, IL-2-183B2scFv, for targeted immunotherapy of ovarian cancer

1 reference

12 December 2020

EpCAM is overexpressed in breast cancer and is a potential target for breast cancer gene therapy

1 reference

12 December 2020

Segmental flexibility and complement fixation of genetically engineered chimeric human, rabbit and mouse antibodies

1 reference

12 December 2020

Vaccination with novel combinations of anti-HER2/neu cytokines fusion proteins and soluble protein antigen elicits a protective immune response against HER2/neu expressing tumors

1 reference

12 December 2020

Problems of delivery of monoclonal antibodies. Pharmaceutical and pharmacokinetic solutions

1 reference

12 December 2020

Rituximab (monoclonal anti-CD20 antibody): mechanisms of action and resistance

1 reference

12 December 2020

The Ch14.18-GM-CSF fusion protein is effective at mediating antibody-dependent cellular cytotoxicity and complement-dependent cytotoxicity in vitro

1 reference

12 December 2020

Safety, pharmacokinetics, and biological pharmacodynamics of the immunocytokine EMD 273066 (huKS-IL2): results of a phase I trial in patients with prostate cancer

1 reference

12 December 2020

Direct in vitro evidence and in vivo analysis of the antiangiogenesis effects of interleukin 12.

1 reference

12 December 2020

A clinical trial with chimeric monoclonal antibody WX-G250 and low dose interleukin-2 pulsing scheme for advanced renal cell carcinoma

1 reference

12 December 2020

A role for chondroitin sulphate B in the activity of interleukin 12 in stimulating gamma-interferon secretion

1 reference

12 December 2020

Arming antibodies: prospects and challenges for immunoconjugates

1 reference

12 December 2020

A single-chain IL-12 IgG3 antibody fusion protein retains antibody specificity and IL-12 bioactivity and demonstrates antitumor activity.

1 reference

12 December 2020

Further characterization of the binding of human recombinant interleukin 2 to heparin and identification of putative binding sites

1 reference

12 December 2020

Combination effect of vaccination with IL2 and IL4 cDNA transfected cells on the induction of a therapeutic immune response against Lewis lung carcinoma cells

1 reference

12 December 2020

Granulocyte-macrophage colony-stimulating factor (GM-CSF) and T-cell responses: what we do and don't know

1 reference

12 December 2020

Capillary leak syndrome during low dose granulocyte-macrophage colony-stimulating factor (rh GM-CSF) treatment of a patient in a continuous febrile state

1 reference

12 December 2020

Positive self regulation of cytotoxicity in human natural killer cells by production of interferon upon exposure to influenza and herpes viruses

1 reference

12 December 2020

Double trans-chromosomic mice: maintenance of two individual human chromosome fragments containing Ig heavy and kappa loci and expression of fully human antibodies

1 reference

12 December 2020

A human cytokine/single-chain antibody fusion protein for simultaneous delivery of GM-CSF and IL-2 to Ep-CAM overexpressing tumor cells.

1 reference

12 December 2020

Bioactive murine and human interleukin-12 fusion proteins which retain antitumor activity in vivo

1 reference

12 December 2020

Peptide-based, but not whole protein, vaccines elicit immunity to HER-2/neu, oncogenic self-protein.

1 reference

12 December 2020

Interleukin-12: a cytokine with therapeutic potential in oncology and infectious diseases

1 reference

12 December 2020

Administration of interleukin 12 with pulse interleukin 2 and the rapid and complete eradication of murine renal carcinoma

1 reference

12 December 2020

Adjuvant trastuzumab: a milestone in the treatment of HER-2-positive early breast cancer

1 reference

12 December 2020

Disialogangliosides GD2 and GD3 are involved in the attachment of human melanoma and neuroblastoma cells to extracellular matrix proteins

1 reference

12 December 2020

Managing toxicities of high-dose interleukin-2.

1 reference

12 December 2020

Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells

1 reference

12 December 2020

Long-term immunity elicited by antibody-cytokine fusion proteins protects against sequential challenge with murine mammary and colon malignancies

1 reference

12 December 2020

Multiple primary tumours in women following breast cancer, 1973-2000

1 reference

12 December 2020

Ep-Cam levels in prostatic adenocarcinoma and prostatic intraepithelial neoplasia

1 reference

12 December 2020

Killing of human tumor cell lines by human monocytes and murine monoclonal antibodies

1 reference

12 December 2020

Potent activation of mouse macrophages by recombinant interferon-gamma

1 reference

12 December 2020

IL-2 and IFN-gamma are two necessary lymphokines in the development of cytolytic T cells

1 reference

12 December 2020

Recombinant anti-human HER2/neu IgG3-(GM-CSF) fusion protein retains antigen specificity and cytokine function and demonstrates antitumor activity

1 reference

12 December 2020

An essential role for HLA-DM in antigen presentation by class II major histocompatibility molecules

1 reference

12 December 2020

Antibodies, Fc receptors and cancer

1 reference

12 December 2020

An IgG3-IL-2 fusion protein recognizing a murine B cell lymphoma exhibits effective tumor imaging and antitumor activity

1 reference

12 December 2020

Anti-ErbB-2 monoclonal antibodies and ErbB-2-directed vaccines

1 reference

12 December 2020

Inhibition of angiogenesis in vivo by interleukin 12.

1 reference

12 December 2020

Granulocyte-macrophage-colony-stimulating factor enhances immune responses to melanoma-associated peptides in vivo

1 reference

12 December 2020

Cytokines in cancer therapy.

1 reference

12 December 2020

The side-effect profile of GM-CSF

1 reference

12 December 2020

The tumor-associated antigens BR55-2, GA73-3 and GICA 19-9 in normal and corresponding neoplastic human tissues, especially gastrointestinal tissues.

1 reference

12 December 2020

Interleukin 2 acts as an adjuvant to increase the potency of inactivated rabies virus vaccine

1 reference

12 December 2020

Ex vivo evaluation of anti-EpCAM immunocytokine huKS-IL2 in ovarian cancer

1 reference

12 December 2020

The Antibody-Mediated Targeted Delivery of Interleukin-15 and GM-CSF to the Tumor Neovasculature Inhibits Tumor Growth and Metastasis

1 reference

12 December 2020

Phase I clinical trial of the immunocytokine EMD 273063 in melanoma patients

1 reference

12 December 2020

Engineered antibody fragments and the rise of single domains

1 reference

12 December 2020

MIG (CXCL9) chemokine gene therapy combines with antibody-cytokine fusion protein to suppress growth and dissemination of murine colon carcinoma.

1 reference

12 December 2020

Immunocytokines: amplification of anti-cancer immunity

1 reference

12 December 2020

Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells

1 reference

12 December 2020

Inhibition of angiogenesis by interleukin-12 is mediated by the interferon-inducible protein 10

1 reference

12 December 2020

Construction, expression and characterisation of a single-chain diabody derived from a humanised anti-Lewis Y cancer targeting antibody using a heat-inducible bacterial secretion vector

1 reference

12 December 2020

Chimeric CLL-1 antibody fusion proteins containing granulocyte-macrophage colony-stimulating factor or interleukin-2 with specificity for B-cell malignancies exhibit enhanced effector functions while retaining tumor targeting properties.

1 reference

12 December 2020

Systematic preclinical study on the therapeutic properties of recombinant human interleukin 2 for the treatment of metastatic disease.

1 reference

12 December 2020

Long-lived and transferable tumor immunity in mice after targeted interleukin-2 therapy

1 reference

12 December 2020

Interleukin-2 and human monocyte activation.

1 reference

12 December 2020

Interleukin-2. A review of its pharmacological properties and therapeutic use in patients with cancer

1 reference

12 December 2020

Antibody engineering via genetic engineering of the mouse: XenoMouse strains are a vehicle for the facile generation of therapeutic human monoclonal antibodies

1 reference

12 December 2020

Carcinoembryonic antigen (CEA) testing in colorectal cancer follow up: what do patients think?

1 reference

12 December 2020

The inclusion of the type III repeat ED-B in the fibronectin molecule generates conformational modifications that unmask a cryptic sequence

1 reference

12 December 2020

Bi-functional cytokine fusion proteins for gene therapy and antibody-targeted treatment of cancer

1 reference

12 December 2020

Pharmacokinetics and stability of the ch14.18-interleukin-2 fusion protein in mice

1 reference

12 December 2020

The IL-2 mediated amplification of cellular cytotoxicity

1 reference

12 December 2020

Continuous cultures of fused cells secreting antibody of predefined specificity

1 reference

12 December 2020

Augmentation of antitumor activity of an antibody-interleukin 2 immunocytokine with chemotherapeutic agents

1 reference

12 December 2020

Two new monoclonal antibodies, Lym-1 and Lym-2, reactive with human B-lymphocytes and derived tumors, with immunodiagnostic and immunotherapeutic potential.

1 reference

12 December 2020

Anti-CD30-IL-12 antibody-cytokine fusion protein that induces IFN-gamma secretion of T cells and NK cell-mediated lysis of Hodgkin's lymphoma-derived tumor cells

1 reference

12 December 2020

Phase IB trial of chimeric antidisialoganglioside antibody plus interleukin 2 for melanoma patients

1 reference

12 December 2020

Enhancement of the antitumor activity of interleukin-12 by targeted delivery to neovasculature.

1 reference

12 December 2020

A repertoire of monoclonal antibodies with human heavy chains from transgenic mice

1 reference

12 December 2020

Targeted therapy of cancer: new prospects for antibodies and immunoconjugates

1 reference

12 December 2020

Antitumor activity of a dual cytokine/single-chain antibody fusion protein for simultaneous delivery of GM-CSF and IL-2 to Ep-CAM expressing tumor cells

1 reference

12 December 2020

T cell memory against colon carcinoma is long-lived in the absence of antigen.

1 reference

12 December 2020

huBC1-IL12, an immunocytokine which targets EDB-containing oncofetal fibronectin in tumors and tumor vasculature, shows potent anti-tumor activity in human tumor models.

1 reference

12 December 2020

Interferon-gamma-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases

1 reference

12 December 2020

Recombinant antibodies: from the laboratory to the clinic

1 reference

12 December 2020

Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface

1 reference

12 December 2020

Insights into the mechanism of anti-tumor immunity in mice vaccinated with the human HER2/neu extracellular domain plus anti-HER2/neu IgG3-(IL-2) or anti-HER2/neu IgG3-(GM-CSF) fusion protein

1 reference

12 December 2020

The transferrin receptor part I: Biology and targeting with cytotoxic antibodies for the treatment of cancer

1 reference

12 December 2020

Intensified antitumor immunity by a cancer vaccine that produces granulocyte-macrophage colony-stimulating factor plus interleukin 4.

1 reference

12 December 2020

Elimination of established murine colon carcinoma metastases by antibody-interleukin 2 fusion protein therapy.

1 reference

12 December 2020

Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor

1 reference

12 December 2020

Mechanisms of macrophage cytotoxicity in IL-2 and IL-12 mediated tumour regression

1 reference

12 December 2020

Immunotherapy of acute and recurrent herpes simplex virus type 2 infection with an adjuvant-free form of recombinant glycoprotein D-interleukin-2 fusion protein

1 reference

12 December 2020

Anaphylactic shock after retreatment with OKT3 monoclonal antibody

1 reference

12 December 2020

Antibody engineering for the development of therapeutic antibodies

1 reference

12 December 2020

Enhanced activity of hu14.18-IL2 immunocytokine against murine NXS2 neuroblastoma when combined with interleukin 2 therapy

1 reference

12 December 2020

A recombinant anti-erbB2, scFv-Fc-IL-2 fusion protein retains antigen specificity and cytokine function

1 reference

12 December 2020

Identifiers

DOI

10.1517/14712598.8.5.609

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18407765%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18407765%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

PubMed publication ID

18407765

1 reference